Effects of Salvia miltiorrhiza after acute myocardial infarction in rats
Ji, Xin-Yan, Tan, Benny Kwong-Huat, Huang, Shan-Hong, Whiteman, Matthew, Zhu, Yi-Chun, Duan, Wei, Zhu, Yi-Zhun and Linz, Wolfgang 2004, Effects of Salvia miltiorrhiza after acute myocardial infarction in rats, in Novel compounds from natural products in the new millennium, World Scientific, Singapore, pp.183-195.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name
Description
MIMEType
Size
Downloads
Title
Effects of Salvia miltiorrhiza after acute myocardial infarction in rats
Formatted title
Effects of Salvia miltiorrhiza after acute myocardial infarction in rats
Novel compounds from natural products in the new millennium
Editor(s)
Tan, Benny K-H Bay, Boon-Huat Zhu, Yi-Zhun
Publication date
2004
Total chapters
30
Start page
183
End page
195
Total pages
13
Publisher
World Scientific
Place of Publication
Singapore
Summary
Acute myocardial infarction (M!) is the commonest cause of death in the developed countries, and it is on the rise in developing countries. Ramipril is a well-knownAngiotensin-converting enzyme (ACE) inhibitorwhich inhibits conversion ofinactive angiotensin I to active angiotensin II. Experimental studies have shown thatACE inhibitors administered chronicallybefore acuteMImight limitmyocardial infarct size, improve cardiac function and prevent cardiac hypertrophy [1, 2]. The Chinese herb, Salvia miltiorrhiza (SM), has been widely and successfully usedmainly for anginapectoris,MI and stroke [3]. Compared to ramipril, however, there is very limited biochemical information availableto demonstrate themechanismsofSMs cardio-protective effects. This study thus investigates the possible biochemical and molecularmechanisms ofsuch effects ofSMin Wistar rats in comparison with those oframipril.